Skip to content

Comparison of the effects of different doses of liposomal bupivacaine on sciatic nerve block on foot and ankle function after total knee arthroplasty (TKA)

Comparison of the effects of different doses of liposomal bupivacaine on sciatic nerve block on foot and ankle function after total knee arthroplasty (TKA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114859
Enrollment
Unknown
Registered
2025-12-18
Start date
2025-04-08
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis and end-stage knee disease

Interventions

Low-dose group:After undergoing total knee arthroplasty (TKA), the patient was transferred to the anesthesia recovery room for observation. Under ultrasound guidance, combined with a nerve stimulator,
Medium-dose group:After undergoing total knee arthroplasty (TKA), the patient was transferred to the anesthesia recovery room for observation. Under ultrasound guidance, combined with a nerve stimulat

Sponsors

Foshan Fosun Chancheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 55 to 80 years old; 2. ASA classification is grade II or III; 3. 18 kg/m^2 or less a BMI of 30 kg/m^2 or less; 4. Unilateral total knee arthroplasty (TKA) under elective combined spinal-epidural anesthesia; 5. The subjects voluntarily participated in this trial and signed the informed Consent Form (ICF).

Exclusion criteria

Exclusion criteria: 1. History of common peroneal nerve injury or neuromuscular diseases; 2. History of severe cardiovascular or cerebrovascular diseases, hepatic or renal dysfunction, cerebral stroke, or peptic ulcer disease. 3. Allergy to local anesthetics or opioids. 4. Communication disability, or history of psychological or psychiatric disorders. 5. Contraindications to regional nerve block (e.g., coagulopathy, local infection at the injection site). 6. History of alcohol abuse, or use opioid or sedative medications preoperatively; 7.The subjects refused to be included in the study.

Design outcomes

Primary

MeasureTime frame
Ankle flexion and extension range of motion;Strength of the dorsiflexor muscles of the ankle;

Secondary

MeasureTime frame
Resting Visual Analogue Scale (RVAS) score and motor Visual Analogue Scale (MVAS) score;Score of numbness degree in the area innervated by the sciatic nerve;

Countries

China

Contacts

Public ContactJiaming Dai

Foshan Fosun Chancheng Hospital

18718708867@163.com+86 187 1870 8867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026